| Items | Drug Registration information |
|---|---|
| ID | 966 |
| No | 966 |
| Brand Name | PEMIMAKS |
| Ingredients | PEMIGATINIB 4.5 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | 42 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | CHOLANGIOCARCINOMA, MYELOID/LYMPHOID NEOPLASM WITH FGFR1 REARRANGEMENT |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE, ROUND, TABLET |
| Note | |
| License Owner | FACTORY NO.2 |
| Manufacturer | FACTORY No.2 |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 01 L 1058/24 |
| FDD Registration Date | 31/01/2024 |
| Expiry Date | 30/01/2027 |